Ömer EMECEN, Murat USTA, Hale ARAL, Berçik Berrin İNAL, Güvenç GÜVENEN, Füsun ERDENEN

Evaluation of oxidant/antioxidant status and ECP levels in asthma

Inflammatory and immune cells, such as eosinophils, macrophages, and neutrophils, generate more reactive oxygen species in patients with asthma than they do in healthy individuals, and oxygen radicals contribute to tissue injury in asthma. We aimed to measure total oxidant status (TOS) and antioxidant status (TAS) in order to assess oxidative and antioxidative capacity. Eosinophil cationic protein (ECP), total IgE, and eosinophils (%) were measured to evaluate the level of inflammation. Materials and methods: The study included 56 non-smoking asthma patients that were followed-up at the respiratory disease and allergy outpatient clinics, where they received ongoing treatment for 5 months (May 2008-October 2008). Patients with malignancy or chronic diseases, such as DM, chronic renal disease, and rheumatoid arthritis, were excluded. The patients with asthma were divided into 2 subgroups according to the level of asthma control: controlled and partially controlled. Results: Despite the absence of statistically significant differences in TAS and TOS in the asthma and control groups (P > 0.05), the levels of ECP, eosinophils, and total IgE were higher in the asthma patients (27.4-16 mg/dL, P = 0.008; 2.8%-1.7%, P = 0.03; 59-19.3 IU/L, P < 0.001, respectively); there were no statistically significant differences between the asthma subgroups. Conclusion: Therapy administered to the asthmatic patients prevented generation of excess oxidants, although eosinophilic inflammation persisted.

Anahtar Kelimeler:

Key words: Asthma, oxidative stress, total oxidant status, total antioxidant status, eosinophil cationic protein

Evaluation of oxidant/antioxidant status and ECP levels in asthma

Keywords:

Key words: Asthma, oxidative stress, total oxidant status, total antioxidant status, eosinophil cationic protein,

PDF

___

Koh GC-H, Shek LP-C, Goh DY-T, Bever HV, Koh DS. Eosinophil cationic protein: Is it useful in asthma? A systematic review. Respiratory Medicine 2007; 101: 696-705. 2.
Reiter RJ. Oxidative process and antioxidative defense
Kirkham P, Rahman I. Oxidative stress in asthma and COPD: Antioxidants as a therapeutic strategy. Pharmacol Ther 2006; 111: 476-494.
Ricciardolo FL, Stefano A, Sabatini F, Folkerts G. Reactive nitrogen species in the respiratory tract. Eur J of Pharmacol 2006; 533: 240-252.
Comhair SAA, Erzurum SC. Antioxidant responses to oxidant- mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 2002; 283: 246-255.
Global Initiative for Asthma Global strategy for asthma management and prevention (updated 2007); Chapter 2: 22-23. www.ginasthma.com
Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry 2004; 37: 277-285.
Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005; 38: 1103-1111.
Riedl MA, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol 2008; 8: 49-56.
Dworski R. Oxidant stress in asthma. Thorax 2000; 55: 51-53.
Zeyrek D, Cakmak A, Atas A, Kocyigit A, Erel O. DNA damage in children with asthma bronchiale and its association with oxidative and antioxidative measurements. Pediatr Allergy Immunol 2009; 20: 370-376.
Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000; 162: 1273-1276.
Hanta I, Kuleci S, Canacankatan N, Kocabas A. The oxidant- antioxidant balance in mild asthmatic patients. Lung 2003; 181: 347-352.
Wood LG, Fitzgerald DA, Gibson PG, Cooper DM. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000; 35: 967-974.
Smith LJ, Shamsuddin M, Sporn PHS, Denenberg M, Anderson J. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radical Biology & Medicine 1997; 22: 1301-1307.
Vural H, Aksoy N, Ceylan E, Gencer M, Ozguner F. Leukocyte oxidant and antioxidant status in asthmatic patients. Arch Med Res 2005; 36: 502-506.
Tekin D, Sin BA, Mungan D, Mısırlıgil Z, Yavuzer S. The antioxidative defense in asthma. Journal of Asthma 2000; 37: 59-63.